37
Views
0
CrossRef citations to date
0
Altmetric
Review

Gaps in patients’ understanding of palliative chemotherapy. Can we better communicate that treatment is not curative?

Pages 245-249 | Received 17 Jul 2017, Accepted 04 Sep 2017, Published online: 11 Sep 2017
 

ABSTRACT

Introduction and Areas covered: Misunderstanding in cancer patients receiving chemotherapy is common. 50% of cancer chemotherapy is given with palliative intent. Many patients receiving chemotherapy for incurable cancer may not understand that chemotherapy is unlikely to be curative.

Cancer patients expect to share treatment decisions with their oncologist. Provision of a question prompt list (QPL) and endorsement by physicians enhances patient participation in consultations and promotes patient questions about prognosis.

Audio-recordings of oncologist consultations with newly detected incurable cancer patients document that most patients were informed about the aim of cancer treatment and that their disease was incurable. Oncologists checked patient understanding in only 10% of consultations.

Expert commentary: This review identifies gaps in patient understanding of palliative chemotherapy and examines incurable cancer patients expectations of treatment.

Acknowledgments

I acknowledge with thanks the contribution of research colleagues to the views expressed in this review. The colleagues are: Phyllis Butow, Martin Stockler, Belinda Kiely, Melina Gattellari, Ron Epstein.

Declaration of interest

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Additional information

Funding

No funding to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.